Fierce Biotech Covers MAP / Lief Therapeutics Strategic Partnership


April 26, 2017   Amirah Al Idrus

Published in Fierce Biotech, April 26, 2017. View the Article Here

MAP Health Management and Lief Therapeutics are tying up to monitor patients with substance use disorder to learn how detecting and addressing elevated anxiety early can improve outcomes for these patients.

Designed to support providers of behavioral health and addiction treatment, MAP’s platform includes telehealth offerings and remote engagement devices and apps. Lief makes a sensor worn on the ribcage that tracks heart and breathing rates to monitor anxiety.

The partners will launch a pilot program next month, MAP said in a statement. It will involve 50 patients already using MAP and who have a history of anxiety issues. They will wear the Lief Smart Patch, which syncs with a mobile app.

MAP will transmit the data collected to a data store, where it will be used to detect elevated anxiety or panic attacks and coordinate care. The system will then send alerts to case managers, who will communicate with individual patients as they experience symptoms.

“About 40% of individuals served by MAP have a history of anxiety issues,” said Jacob Levenson, CEO of MAP Health Management, in the statement. “What’s very clear in our data is that people in recovery from addiction but with untreated anxiety issues tend to have poor outcomes. We believe that elevated anxiety is a leading indicator of a potential return to substance use. The Lief Smart Patch is going to enable us to get actionable data in real-time to change the trajectory and affect a better outcome.”

The duo plans to present population-level data to national insurance carriers and health systems showing how effectively treating anxiety in people with substance use disorder can affect clinical outcomes and costs.

The partnership with Lief is just the latest in a series for MAP. In February, the company teamed up with Intent Solutions to monitor medication adherence in people with substance use disorder. The pilot program had patients whose risk of relapse was already being monitored by MAP use Intent’s smart, portable medication dispenser. The biometric device, called TAD, dispenses the right dose at the right time and connects to a mobile app to tell patients when to take their medication.


#
If we want to reverse the growing trend of suicide in America, we have to take a hard look at the underlying…
#
Peer Recovery Support Specialists (PRSSs), also known as peer support providers or peer recovery coaches, are an…
#
First responders in Newark confront accidental opioid poisoning multiple times a shift. It has become commonplace…
#
We are in the midst of a crisis of untreated and undertreated mental health and substance use disorders. The…
#
A growing body of research seems to suggest that this rise in the popularity of Cryptocurrencies havw also possibly…
#
The addiction epidemic, including the current opioid crisis, has brought the level of addiction-related…
#
"Those who suffer deserve a proper medical/clinical label to destigmatize this life-threatening disease, and move…
#
This exploration to find what causes addiction often leads to blaming one source over another, adding to its…
#
The payer-provider relationship is always evolving, especially in the transition from fee-for-service healthcare to…
#
Technology, Information, and the Internet are reshaping our youth in some positive and some very negative ways, and…